Week 329 Review - The nightmare continues with greater losses than last week

What an utterly depressing week. You can tell it's bad when my biggest riser was 0%. The crash on Friday caused by the new strain of Covid did the most damage, and although the gold price rebounded, it wasn't enough to undo all the big drops from earlier in the week. The deficit between cost and value widened by £7,607 to £49,215 and portfolio value dropped to £104,819. If it drops below £100k I'm going to have a very miserable Christmas.

JLP:Jubilee Metals was the worst performer dropping 14% of my purchase price, but it was a relatively small percentage of the current price.

IQE:IQE gave a trading statement that was effectively a profit warning, and despite all the chip manufacturers gaining massively due to chip shortages, IQE is managing to do even worse than usual and fell 10% this week.

I'll cover all the gold mines together as they all dropped early in the week, but failed to catch up after the price of gold went back above $1,800. PAF:Pan African Resources dropped 12%, Blackrock World Gold Fund dropped 7%, CEY:Centamin dropped 6% and POLY:Polymetal also dropped 6%.

DDDD:4D Pharma is my 2nd biggest holding and the lack of news coupled with a forced large seller saw the price drop 8% making these worth half what I bought them for.

My largest holding OPTI:Optibiotix dropped 5% to the lowest they have been for a long time. News is expected before Christmas, but at this rate it's only going to lift us back to the 50p range and will still be losing money.

There's no Share of the Week because nobody deserved it. My highest risers were CAML:Central Asia Metals and IGG:IG Group, but they both climbed by less than 1% so there's absolutely no silver lining to my cloud of misery.

Getting dangerously close to the injection line

It's very difficult to keep one's pecker up when the relentless decline has been going on for almost a year.

Here's the ISA and shares portfolio after week 17 of year 7.

			Weekly Change
Cash	£10.15		+£0
Portfolio cost	£71,348.76		+£0
Portfolio sell value (bid price-commission)	£48,700.05	(-31.7%)	-£3,560.53
Potential profits	£2,875.09		-£150.00
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,095.94		+£0
Yr 7 projected avg monthly profit	£791.94	(21.6%)	-£49.50
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,219.88		+£0
Average monthly cash profit	£372.65	(10.2%)	-£1.13
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	64%		+0%

Massive losses and potential profits down £150 as JLP:Jubilee Metals dropped. The only ray of light is that my long term performance is above 10% target, but it's hard to get enthused when your portfolio is down by 31%.

Plunging towards the injection line

After getting so close to crossing the trend line, now we're well below it.

The SIPP looks like this after week 313 overall and week 1 of year 7.

			Weekly Change
Cash	£174.89		+£0
Portfolio cost	£79,867.72		+£30.00
Portfolio sell value (bid price - commission)	£54,665.46	(-31.6%)	-£3,899.75
Potential profits	£346.76		-£146.49
Yr 7 Dividends	£0		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£0		+£0
Yr 7 projected avg monthly profit	£0	(0%)	+£0
Total Dividends	£3,204.39		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,724.63		+£0
Average monthly cash profit	£361.44	(8.8%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	53%		+0%

The portfolio cost went up £30 because rather annoyingly Hargreaves Lansdown keeps automatically investing my tax rebate, so given the same thing will happen next month there's no point in me selling the gold fund yet. The £30 bought another 1.26 units of Blackrock World Gold fund at 2380.95238p so the good news was that the purchase was made just after the gold price dropped.

This is the first week of year 7 so all the annual stats have been set to zero. Potential profits dropped but not by as much as I feared, but massive drop in value across the board.

This would be less depressing if the cost line wasn't going up so much. The next chart will be more revealing

Crashing back below the trend line. What an utterly rubbish year!

The trading account looks like this after week 279 overall and week 19 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,009.91	(-57.5%)	-£147.65
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.50	(7.8%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

One of the biggest ever weekly drops. Was it really just a few weeks ago I was suggesting my DDDD:4D Pharma holding might get into profit soon?

I'll have to adjust the chart to show a lower value next week if we drop any further

A brief dalliance above the trend line didn't last long.

I'm too miserable to write any more.

Week 328 Review - Utter misery as all recent gains wiped out

A desperately awful week, with all the recent trickle of gains gone. The deficit between cost and value widened by £4,990 to £41,607 and portfolio value dropped to £112,398.

Worst performer was DDDD:4D Pharma which lost 9% only a week after celebrating a 7% rise. That's all gone and so has a bit more, and with this being my 2nd biggest holding a 9% drop is horrible.

OPTI:Optibiotix only dropped 3%, but that 2p cost me £3,400 of the losses. I thought news of a new India subsidiary would give the price a boost, but good news always results in a drop for OPTI. It's probably because the good news never has a sum of money attached, and people need to see that to want to buy the shares.

Only one share increased by more than 5%, so Share of the Week is JLP:Jubilee Metals which climbed exactly 5%. That's hardly anything for JLP, as it doesn't take much to climb 5% of my purchase price. They are still 278% up, but a long way from where I thought they would be by now and from the highs of a few months ago.

Weeks of effort to climb a relatively small way, all wiped out in one go.

Such a brief dalliance above the trend line. I think I'm entitled to be annoyed.

Here's the ISA and shares portfolio after week 16 of year 7.

			Weekly Change
Cash	£10.15		+£0
Portfolio cost	£71,348.76		+£0
Portfolio sell value (bid price-commission)	£52,260.58	(-26.8%)	-£2,400.14
Potential profits	£3,025.09		+£50.00
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,095.94		+£0
Yr 7 projected avg monthly profit	£841.44	(23.0%)	-£56.09
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,219.88		+£0
Average monthly cash profit	£373.78	(10.2%)	-£1.14
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	64%		+0%

Potential profits up £50 thanks to JLP:Jubilee Metals, but overall value down £2,400 thanks to most other things doing rubbish.

Nearly wiped out weeks of gains

Just as we were approaching the trend line, down we go to the worst deficit of the last 12 months.

The SIPP looks like this after week 312 overall and week 52 of year 6.

			Weekly Change
Cash	£174.89		+£21.38
Portfolio cost	£79,837.72		+£300.65
Portfolio sell value (bid price - commission)	£58,535.21	(-26.7%)	-£2,514.71
Potential profits	£493.25		-£68.42
Yr 6 Dividends	£1,137.31		+£22.03
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£8,265.19		+£0
Yr 6 projected avg monthly profit	£766.77	(18.7%)	-£13.16
Total Dividends	£3,204.39		+£22.03
Total Interest	£0.20		+£0
Total Profit from sales	£23,724.63		+£0
Average monthly cash profit	£362.60	(8.9%)	-£0.86
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	53%		+0%

I had a £22 dividend from PLUS:Plus500 which sees the good run of dividends come to an end until PAF:Pan African Resources at the end of December.

I added £300 because I wanted to get a few more TLOU:Tlou Energy, as things are progressing really well and I think there will be a re-rate soon. I bought 9,209 shares at 3.135p costing £300.65 to take my SIPP holding to a nice round 80,000 shares. Add to that the 40,000 I have in my ISA and I'm hopeful for a big return.

This was the last week in year 6, and I'm really happy with the average returns of £766 (18.7%) a month. That's almost twice my target and has really helped get the long term average back up around 9% after drifting over the last few years. It's hard to keep the performance up with this account because I keep adding more cash, so the average percentage is hit every time. It's still good to maintain a difficult target though.

Here's a summary of the year 6 profits minus a couple of losses that gave the 18.7% return

CAML:Central Asia Metals: £3,798

SBTX:SkinBioTherapeutics: £2,051

Dividends: £1,137

FXPO:Ferrexpo: £973

ITV:ITV: £611

POLR:Polar Capital Holdings: £565

APAX:Apax Global Alpha: £324

ITX:Itaconix: £202

Blackrock World Gold Fund: £24

PAY:Paypoint: £23

ASHM:Ashmore Group: -£104

CMCL:Caledonia Mining: -£205

Over £2,000 and a decent chunk of the dividends were from magic formula shares, so I'm happy with that tactic and will continue with it. The current tranche are doing pretty badly, but there are 6 months to go before I review them and they are all paying good dividends so I'm quietly confident in their long term prospects.

This appears much less of a drop than the ISA.

Still just above the trend line which is quite a boost to the morale in a difficult week.

The trading account looks like this after week 278 overall and week 18 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,157.56	(-51.2%)	-£75.47
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.56	(7.9%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

Big hit from the 9% drop in DDDD:4D Pharma takes us back above 50% losses and crushes my optimism that some profit was nearing.

Not as low as a few months ago, but a big dip

Amazingly still above the trend line so maybe there's a glimmer of hope

I thought the Santa rally had started, but this week has undone most of it, so I really don't know now. Most of my gold miners were down on the week despite the price of gold holding up, so I suspect there's been some profit taking. Even if the majority of my smaller holdings bounce back next week, unless DDDD:4D Pharma and OPTI:Optibiotix start showing some sort of recovery, then I'm stuck in the doldrums just waiting for some good news. Not just good news, but good news with a financial figure attached to it.

Week 327 Review - Great week as gold heads upwards

This week saw increases all over the portfolio, but particularly in the gold and metals shares. The deficit between cost and value narrowed by £2,747 to £36,616 and total portfolio value increased to £117,065.

The only big loser was BLU:Blue Star Capital which dropped 6%. This wasn't a surprise after last week's 15% rise as traders took profits. Hopefully now they are out of the way the price will recover next week.

FXPO:Ferrexpo has had a torrid time lately, but gained 5% this week. My holding is still down by 33%in the 7 months since I bought them. I only have 5 months for them to make up the loss before I review whether to sell, but if they stay at this level I won't be selling, but will enjoy the big dividend and will likely add some more.

WHR:Warehouse REIT had been slipping a bit, but put on 5% this week to go 9% up in the 6 weeks I have owned them. Hopefully this will be a well behaved magic formula share and stay in profit until I sell them next September.

CAML:Central Asia Metals, CMCL:Caledonia Mining and POLY:Polymetal all climbed 7% this week. All are around the same size holding now I've sold a lot of my CAML shares. My ISA POLY holding is only 1% down now, and was designed to be a short term holding, so I'll be looking to sell those if they get to around 10% profit so I can invest somewhere else. That might be SBTX:SkinBioTherapeutics if the price can just drop to 50p, else it's hard to resist topping up OPTI:Optibiotix again.

Blackrock World Gold Fund climbed 8% and went into profit, but I only have £30 worth and only have them by accident after Hargreaves Lansdown invested my tax rebate unexpectedly. I may sell them very soon as they're not really worth reporting on.

JLP:Jubilee Metals has been slipping for weeks, but gained 9% this week. I think results are due very soon which could see us back to 20p.

CEY:Centamin has been a bit of a disaster since I bought in June, but climbed 9% this week as the gold price surged. They are only 11% down now so I'm hopeful of getting into profit soon if the gold price stays up.

TRX:Tissue Regenix also climbed 9% this week, which was very fortuitous as I bought some more on Monday. I decided that now medical operations are starting up again after Covid, and given the deals they put in place about 18 months ago, then these could reach break even soon and that should trigger a significant re-rate. I bought 62,953 shares at 0.5715p costing £371.73. This is less than my usual £500 minimum purchase, but I only wanted to buy enough to take my holding to 250,000 shares. That reduced my average price to 1.35p, and with the bid price rising to 0.6p this week, my new shares are already in profit but my overall holding is still 57% down. I think 2p is achievable when they become profitable, which would give me £1,500 profit, but I'll probably hold them long term in the hope they get bought out for significantly more.

Share of the week is PAF:Pan African Resources, which I only bought last week. They climbed 14% and are 17% in profit which would give me £172. However, I have to keep them until next November if I obey the magic formula rules. There's a healthy dividend next month, so I do want to keep them anyway.

Nice continuation of the steady ramp up, but still nearer the injection line than the cost line.

Back above the trend line after being below it for the majority of this year. Can we stay above it with a Santa rally?

Here's the ISA and shares portfolio after week 15 of year 7.

			Weekly Change
Cash	£10.15		+£0
Portfolio cost	£71,348.76		+£0
Portfolio sell value (bid price-commission)	£54,660.72	(-23.4%)	+£1,083.66
Potential profits	£2,975.09		+£100.00
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,095.94		+£0
Yr 7 projected avg monthly profit	£897.53	(24.5%)	-£64.11
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,219.88		+£0
Average monthly cash profit	£374.92	(10.2%)	-£1.15
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	64%		+0%

Potential profits up a nice even £100 now I've rounded off my JLP:Jubilee Metals holding to 25,000 shares. It was nearly a less rounded number with POLY:Polymetal getting into profit on Thursday before dropping back to £6 loss on Friday. Maybe next week...

Overall value up by £1,083 helped by a 1p increase in OPTI:Optibiotix which accounted for £850 of the rise. Long term performance still above target 10% which is deeply pleasing.

Slowly does it.

A less even climb on this one as we alternate between up and down, but that has been impacted by some profit taking. Still well below the trend line so a long way to go.

The SIPP looks like this after week 311 overall and week 51 of year 6.

			Weekly Change
Cash	£153.51		-£98.51
Portfolio cost	£79,537.07		+£478.51
Portfolio sell value (bid price - commission)	£60,749.27	(-23.6%)	+£1,652.89
Potential profits	£561.67		+£286.11
Yr 6 Dividends	£1,115.28		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£8,265.19		+£0
Yr 6 projected avg monthly profit	£779.93	(19.2%)	-£15.60
Total Dividends	£3,182.36		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£23,724.63		+£0
Average monthly cash profit	£363.46	(8.9%)	-£1.17
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	53%		-1%

A couple of purchases this week, with the TRX:Tissue Regenix buy already mentioned, and AJ Bell did my monthly investment in iShares Physical Gold Fund, buying 4 units at 2631.9p costing £106.78. Added to my existing holding, those are up 4% but only making £7 potential profit. I'm intending for these to be a very long term holding as I gradually move out of higher risk gold mines into this fund.

A great week all over the portfolio, with the 1p rise in OPTI:Optibiotix contributing £820 meaning there were gains of over £800 elsewhere, and potential profits up by £286 with 5 holdings in profit.

I was meant to get a dividend from PLUS:Plus500 on Friday but it hasn't appeared in my account yet so that will be accounted for next week, then no more dividends due until PAF:Pan African Resources on 14th December.

Long term performance fell just below 9% due to the increase in injection amount, but with just one week to go of year 6, it's going to be a barnstorming 18%+ year. I'll do a full breakdown of where the profits came from next week.

Still closer to injection than to cost so I don't want to get carried away with joy.

A great punch through the trend line, but it's going to take some flattening after a desperately bad year. I guess one of the reasons it's so bad is I've cashed in a lot of profit, each time damaging this chart.

The trading account looks like this after week 277 overall and week 17 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,233.03	(-48.1%)	+£10.88
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.61	(7.9%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

Virtually no change, although all the shares were up, just by very tiny amounts.

Still below the injection line, which is bad.

Staying above the trend line, and with a genuine hope that DDDD:4D Pharma can break out before Christmas and HUM:Hummingbird Resources take advantage of the higher gold price, we could get a steep recovery here soon.

The performance over the next few weeks is all going to come down to news flow. There are loads of things pending announcement from both OPTI:Optibiotix and DDDD:4D Pharma which could easily double the share price of both. Results for JLP:Jubilee Metals could cause a re-rate if any money is being made from copper, and if the price of gold stays above $1,800 then the miner rally could continue and get them into profit in my portfolio.

Week 326 Review - Great week despite Optibiotix dropping as 4D Pharma flies

This would have been a positive week if I hadn't banked some profit, despite OPTI:Optibiotix dropping 1p which costs me £1,700. Thankfully an epic recovery from DDDD:4D Pharma erased that loss and the gap between cost and value only widened by £311 to £39,354 but total portfolio value went up to £113,947 mainly thanks to a pension transfer injection.

CAML:Central Asia Metals was the worst performer, dropping 9% as metals prices eased.

FXPO:Ferrexpo was hit by the same problem, dropping 6%.

BLU:Blue Star Capital nearly won Share of the Week after climbing 15% on news that SatoshiPay might actually end up worth something. Things could move quite quickly here now, but my holding is still 70% down so a long way to go.

Share of the Week is DDDD:4D Pharma which shot up 15% on news that a new clinical trial is due to start soon. It hasn't started, but the fact the trial has appeared on the registration website got everyone excited. I suspect most of the rise was people closing their short positions. I'm still 32% down so a long way from breakeven, but as this is my 2nd largest holding it negated the 1p drop in OPTI:Optibiotix.

The pension fund injection and re-invested profits caused quite a spike in the cost, with value continuing the same very slow upwards momentum.

This chart reveals the truth. A slight tick downwards and still below the trend line.

Here's the ISA and shares portfolio after week 14 of year 7.

			Weekly Change
Cash	£10.15		-£10.64
Portfolio cost	£71,348.76		+£857.76
Portfolio sell value (bid price-commission)	£53,577.06	(-24.9%)	-£563.96
Potential profits	£2,875.09		-£873.31
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,095.94		+£850.87
Yr 7 projected avg monthly profit	£961.64	(26.3%)	+£208.40
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,219.88		+£850.87
Average monthly cash profit	£376.07	(10.3%)	+£10.13
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	64%		+2%

I sold 7,253 shares in JLP:Jubilee Metals making £850.87 (262.5%) profit and re-invested in OPTI:Optibiotix, buying 2,394 shares at 48.37p costing £1,169.93. That brought my average price in the ISA down to 59.7p. Seems a long time since my average was 84p! My JLP holding is down to 25,000 shares from 150,000 before I started selling. I have however banked £10,152 profit, so although I'll never make a huge amount if these really take off, it's been my most profitable share ever, and I intend to hold the last 25,000. I just couldn't resist another OPTI top-up at these crazy prices when news is so close.

Portfolio value only dropped £563 so would have been slightly up if I hadn't sold. Massive boost to year 7 performance and long term performance is above 10% target.

Still an alarming way below the cost line

Still well below the trend line.

The SIPP looks like this after week 310 overall and week 50 of year 6.

			Weekly Change
Cash	£252.02		-£409.61
Portfolio cost	£79,058.56		+£2,703.78
Portfolio sell value (bid price - commission)	£58,617.87	(-25.9%)	+£129.34
Potential profits	£275.56		-£100.49
Yr 6 Dividends	£1,115.28		+£20.94
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£8,265.19		+£0
Yr 6 projected avg monthly profit	£795.53	(19.7%)	-£15.87
Total Dividends	£3,182.36		+£20.94
Total Interest	£0.20		+£0
Total Profit from sales	£23,724.63		+£0
Average monthly cash profit	£364.63	(9.0%)	-£1.12
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	54%		-3%

I received my £2,200 pension transfer, and with the cash from recent sales had £2,700 to re-invest. I started off sensibly, adding a new magic formula share with gold miner PAF:Pan African Resources. This is a company I have owned before and like a lot, although I was nervous about potential workforce unrest when I last sold them, but that seems to have been resolved. I bought 6,062 shares at 16.4936p costing £1,016.79. Happy to say they went up to 17.52p in a few days and are already 3% up with potential profit of £33.

I spent the rest on OPTI:Optibiotix, buying 3,468 shares at 48.3p costing £1,686.99. That brings my SIPP average price down to 60.3p so I'm still 22% down. My total OPTI holding is now 171,405 costing a truly shocking £103,322. I remember vowing to stop buying after 100,000, and I would have done if the price had returned to a more sensible level, but the longer it stays this low, the longer I will keep buying more. I often moan about the share price, but if it hadn't been so low I wouldn't have anywhere near this many shares.

If the share price hits 584p, my holding will be worth £1 million. I think that's readily achievable. At that price a 5% dividend will be worth £50,000 a year and I can retire on this holding alone.

Meanwhile I got a £20 dividend from ASY:Andrews Sykes Group and the increase in injection value dropped my long term performance down to 9%, a whole percent off target so I need my magic formula shares to turn themselves around before I sell them next summer.

All three lines lifting together.

Pretty much flat but on the trend line so can we get above it next week and start pulling it in the other direction?

The trading account looks like this after week 276 overall and week 16 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£1,222.15	(-48.5%)	+£123.51
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.67	(7.9%)	-£0.06
(Sold stocks profit + Dividends - Fees / Months)

A great week, with value increasing by £123 and getting back above 50% loss. The main question now is how far DDDD:4D Pharma can go. Sometimes when the momentum strikes pharma companies they re-rate very quickly. If that happens I'll be able to sell 2 out of 5 of my trading account holdings and get things moving again here.

Lots of celebrating the big rise, but back down to earth that the value is still below the injection line.

A massive boost to the morale to get above the trend line. Lets hope it's for longer than last time.

I enjoy writing up the blog when there's been lots of buying and selling, but need to face the fact that we're in for a fairly dull time for the next few months, as I've sold down my JLP:Jubilee Metals and CAML:Central Asia Metals shares as far as I'm prepared to. They are both pretty much back at the level of a magic formula share with a £1,000 cost. I do worry that my need to see some tangible profit will prevent me holding shares long enough to appreciate their true value. It's not a mistake I intend to make with OPTI:Optibiotix because I need that gigantic dividend for my retirement plans, so the more shares I own, the greater the dividend. I'm also still counting on an allocation of SBTX:SkinBioTherapeutics shares or cash based on the size of my OPTI holding. If they get dished out even at 1 share for every 10 OPTI shares, that still gives me 17,000 worth £10,000, and it could be even more than that potentially.

All eyes will be on DDDD:4D Pharma next week, as the Nasdaq shares carried on upwards on Friday, so we may get another 10% rise early doors, and then see if the momentum continues. If Friday was mainly closing shorts, then maybe the genuine buyers will come in during the week.